HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: Acquisition of antigen processing and presentation capacity

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 814-820

  Sartoris, Silvia ^a   Valle, Maria Teresa ^b   De Barbaro, Andrea Lerma ^c   Tosi, Giovanna ^c   Cestari, Tiziana ^a   D'Agostino, Antonella ^c   Megiovanni, Anna Maria ^b   Manca, Fabrizio ^b   Accolla, Roberto S ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Advanced Biotechnology Center   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HLA ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIUM TUBERCULOSIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 0032528424     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Germain, R. N. 1994. MHC dependent antigen processing and peptide presentation: providing ligands for lymphocyte activation. Cell 76:287.
2. Accolla, R. S., L. Adorini, S. Sartoris, F. Sinigaglia, and J. Guardiola. 1995. MHC: an integrated genetic system which orchestrates the immune response. Immunol. Today 16:8.
3. Nepom G. T., and H. Erlich. 1991. MHC class II molecules and autoimmunity. Annu. Rev. Immunol. 9:493.
4. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
5. Accolla, R. S., M. T. Scupoli, C. Cambiaggi, G. Tosi, and S. Sartoris. 1991. Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. Int. J. Cancer 6:20.
6. Scupoli, M. T., S. Sartoris, G. Tosi, M. G. Ennas, M. Nicolis, T. Cestari, G. Zamboni, G. Martignoni, N. R. Lemoine, A. Scarpa, and R. S. Accolla. 1996. Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. Tissue Antigens 48:301.
7. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681.
8. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class II transcription. Annu. Rev. Immunol. 10:13.
9. Sartoris, S., and R. S. Accolla. 1995. Transcriptional regulation of MHC class II genes. Int. J. Clin. Lab. Res. 25:71.
10. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
11. Accolla, R. S., M. Jotterand-Bellomo, L. Scarpellino, A. Maffei, G. Carra, and J. Guardiola. 1986. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J. Exp. Med. 164:369.
12. Accolla, R. S. 1983. Human B cell variants immunoselected against a single Ia subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1053.
13. Rigaud, G., A. De Lerma Barbaro, M. Nicolis, T. Cestari, D. Ramarli, A. P. Riviera, and R. S. Accolla. 1996. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-γ. J. Immunol. 156:4254.
14. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
15. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P. Y. Ting. 1994. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
16. Chang, C.-H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
17. Maffei, A., L. Scarpellino, M. Bernard, G. Carra, M. Jotterand-Bellomo, J. Guardiola, and R. S. Accolla. 1987. Distinct mechanisms regulate class II gene expression in B cells and macrophages. J. Immunol. 139:942.
18. Sartoris, S., M. T. Scupoli, L. Scarpellino, F. Paiola, M. Jotterand-Bellomo, G. Tridente, and R. S. Accolla. 1990. Inducible and constitutive MHC class II gene expression. J. Immunol. 145:1960.
19. Latron, F., M. Jotterand-Bellomo, A. Maffei, L. Scarpellino, M. Bernard, J. L. Strominger, and R. S. Accolla. 1988. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc. Natl. Acad. Sci. USA 85:2229.
20. Dellabona, P., F. Latron, A. Maffei, L. Scarpellino, and R. S. Accolla. 1989. Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. J. Immunol. 142:2902.
21. Silacci, P., A. Mottet, V. Steimle, W. Reith, and B. Mach. 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1329.
22. Sartoris, S., G. Tosi, A. De Lerma Barbaro, T. Cestari, and R. S. Accolla. 1996. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Eur. J. Immunol. 26:2456.
23. Ostrand-Rosenberg, S. 1994. Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr. Opin. Immunol. 6:722.
24. + T cells in cancer immunotherapy. Curr. Opin. Immunol. 6:741.
25. Daar, A. S., S. V. Fuggle, J. W. Fahre, A. Ting, and P. J. Morris. 1984. The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38:293.
26. Krief, P., B. Azzarone, C. Boucheix, C. Billard, C. Chang, W. Fiers, and G. Carloni. 1988. Different levels of interferon-γ induction of class I and class II major histocompatibility antigens in human hepatoma cell lines. In Viral Hepatitis and Liver Disease. P. Thiollais, ed. A. R. Liss, Inc., New York, N.Y. p. 217.
27. Paroli, M., G. Carloni, A. Franco, G. De Petrillo, E. Alfani, A. Perrone, and V. Barnaba. 1994. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction. Immunology 82:215.
28. Franco, A., V. Barnaba, P. G. Natali, C. Balsano, A. Musca, and F. Balsano. 1988. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8:449.
29. Volpes, R., J. J. van den Oord, and V. J. Desmet. 1990. Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology 12: 148.
30. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
31. De Bruin, J., K. Huygen, R. Bosnians, M. Fauville, R. Lippens, J.-P. Van Vooren, P. Falmagne, M. Weck, H. G. Wiker, M. Harboe, and M. Turneer. 1987. Purification, characterization and identification of a 32 kDa protein antigen of M. bovis BCG. Microb. Pathog. 2:351.
32. Manca, F., G. Rossi, M. Valle, S. Lantero, G. Damiani, G. Li Pira, and F. Celada. 1991. Limited clonal heterogeneity of antigen specific T cells focussing in the pleural space during mycobacterial infection. Infect. Immun. 59:503.
33. Manca, F., D. Fenoglio, G. Li Pira, A. Kunkl, and F. Celada. 1991. Effect of antigen-antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 173:37.
34. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851.
35. Lennon, A. M., C. Ottone, G. Rigaud, L. L. Deaven, J. Longmire, M. Fellous, R. Bono, and C. Alcaïde-Loridan. 1997. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 45:266.
36. Kem, I., V. Steimle, C.-A. Siegrist, and B. Mach. 1995. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1295.
37. Siegrist, C.-A., E. Martinez-Soria, I. Kern, and B. Mach. 1995. A novel antigen-processing-defective phenotype in major histocompatibility complex class II positive CIITA transfectants is corrected by interferon-γ. J. Exp. Med. 182:1793.
38. Armstrong, T. D., V. K. Clements, B. K. Martin, J. P. Y. Ting, and S. Ostrand-Rosenberg. 1997. Major histocompatibility complex-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc. Natl. Acad. Sci. USA 94:6886.
39. Lanzavecchia, A. 1996. Mechanism of antigen uptake and presentation. Curr. Opin. Immunol. 8:348.
40. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
41. Altmann, D. M., N. Hogg, J. Trowsdale, and D. Wilkinson. 1989. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 338:512.